Genesystem Co., Ltd. (KOSDAQ:363250)
10,500
+460 (4.58%)
Last updated: May 12, 2025
Genesystem Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 |
---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 5,623 | 9,090 | 16,837 |
Short-Term Investments | 2,071 | 5,258 | 8,000 |
Trading Asset Securities | - | - | 1,652 |
Cash & Short-Term Investments | 7,694 | 14,348 | 26,489 |
Cash Growth | -46.37% | -45.84% | - |
Accounts Receivable | 1.78 | 74.38 | 395.53 |
Other Receivables | 109.14 | 135.91 | 162.96 |
Receivables | 110.92 | 210.29 | 558.5 |
Inventory | 1,945 | 3,094 | 3,194 |
Prepaid Expenses | 91.98 | 88.72 | 109.56 |
Other Current Assets | 138.96 | 3,299 | 111.34 |
Total Current Assets | 9,982 | 21,039 | 30,462 |
Property, Plant & Equipment | 8,652 | 6,499 | 6,012 |
Long-Term Investments | 4,278 | 3,612 | 3,895 |
Goodwill | 283.12 | 283.12 | - |
Other Intangible Assets | 6,593 | 7,320 | 684.14 |
Other Long-Term Assets | 114.74 | 174.37 | 128.83 |
Total Assets | 29,902 | 38,928 | 41,183 |
Accounts Payable | 3.13 | 8.26 | - |
Accrued Expenses | 142.69 | 316.6 | 194.6 |
Short-Term Debt | 850 | 850 | 850 |
Current Portion of Long-Term Debt | 923.24 | 423.24 | 90 |
Current Portion of Leases | 78.44 | 107.26 | 68.16 |
Current Unearned Revenue | - | - | 35.02 |
Other Current Liabilities | 540.31 | 726.24 | 728.2 |
Total Current Liabilities | 2,538 | 2,432 | 1,966 |
Long-Term Debt | 2,256 | 3,039 | 3,000 |
Long-Term Leases | 13.53 | 68.4 | 86.89 |
Long-Term Deferred Tax Liabilities | 1,739 | 1,391 | - |
Other Long-Term Liabilities | 226.35 | 231.47 | 164.91 |
Total Liabilities | 8,021 | 8,244 | 6,073 |
Common Stock | 3,516 | 3,492 | 3,465 |
Additional Paid-In Capital | 12,031 | 11,746 | 52,383 |
Retained Earnings | 3,169 | 12,085 | -20,963 |
Treasury Stock | -1,518 | - | - |
Comprehensive Income & Other | 2,074 | 133.13 | 225.89 |
Total Common Equity | 19,273 | 27,456 | 35,110 |
Minority Interest | 2,609 | 3,227 | - |
Shareholders' Equity | 21,881 | 30,684 | 35,110 |
Total Liabilities & Equity | 29,902 | 38,928 | 41,183 |
Total Debt | 4,121 | 4,488 | 4,095 |
Net Cash (Debt) | 3,574 | 9,860 | 22,394 |
Net Cash Growth | -63.75% | -55.97% | - |
Net Cash Per Share | 521.91 | 1418.81 | 3243.47 |
Filing Date Shares Outstanding | 6.8 | 6.98 | 6.93 |
Total Common Shares Outstanding | 6.8 | 6.98 | 6.93 |
Working Capital | 7,444 | 18,608 | 28,496 |
Book Value Per Share | 2833.77 | 3930.80 | 5066.46 |
Tangible Book Value | 12,397 | 19,853 | 34,426 |
Tangible Book Value Per Share | 1822.74 | 2842.23 | 4967.73 |
Land | 5,915 | 3,538 | 3,538 |
Buildings | 1,637 | 1,637 | 1,637 |
Machinery | 2,167 | 1,934 | 1,150 |
Construction In Progress | - | 37.75 | 21.42 |
Updated Nov 14, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.